- Home
- RCUS vs TRMK Comparison
RCUS vs TRMK Comparison
Compare RCUS & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | TRMK |
|---|---|---|
| Founded | 2015 | 1889 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RCUS | TRMK |
|---|---|---|
| Price | $24.31 | $44.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | $31.90 | ★ $44.50 |
| AVG Volume (30 Days) | ★ 1.0M | 321.6K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.26% |
| EPS Growth | N/A | ★ 1.93 |
| EPS | N/A | ★ 0.95 |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | $9.82 |
| Revenue Next Year | $45.62 | $4.86 |
| P/E Ratio | ★ N/A | $46.95 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.92 | $35.96 |
| 52 Week High | $28.72 | $46.34 |
Technical Indicators
Market Signals| Indicator | RCUS | TRMK |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 51.44 |
| Support Level | $23.91 | $43.20 |
| Resistance Level | $24.33 | $45.48 |
| Average True Range (ATR) | 1.45 | 0.89 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 57.31 | 52.29 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About TRMK Trustmark Corporation
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.